Switching From Semaglutide to Tirzepatide For Weight Loss (Is it Safe?)

Weight loss medications are becoming increasingly popular as more individuals look for ways to tackle obesity and related health conditions. 

‍

Two weight loss Injectables that have shown promising results are semaglutide and tirzepatide. While semaglutide is effective in weight loss, some people might not achieve their desired 

‍

results with it and may consider switching to tirzepatide, a newer drug. This transition can be complex, involving factors like efficacy, side effects, and overall health.

‍

In this article, we will compare semaglutide and tirzepatide, discuss possible reasons for switching drugs, and discuss how to switch safely.

Key Takeaways

• Semaglutide and tirzepatide are effective weight loss medications with unique mechanisms of action and efficacy.
• Tirzepatide may be slightly more effective in weight loss than semaglutide, but it can also have more side effects.
• Switching from Semaglutide to tirzepatide should always be done under the supervision of your healthcare provider.

What is Semaglutide?

Semaglutide is a glucagon-like peptide-1 receptor (GLP-1) agonist for blood sugar control and weight loss. This drug was initially approved for treating type 2 diabetes but soon gained popularity for its weight loss benefits. Subsequently, the FDA approved Wegovy, a brand of semaglutide, for weight loss. Ozempic, the semaglutide brand approved for type 2 diabetes, can also be prescribed off-label for weight management. Due to the shortage of the branded options, you can get compounded semaglutide online.

What is Tirzepatide?

Tirzepatide is an antidiabetic drug with dual actions on two distinct receptors: the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1. 

‍

This drug is available under two brands, Mounjaro and Zepbound, which are FDA-approved for type 2 diabetes and weight loss, respectively. 

‍

However, healthcare providers may prescribe Mounjaro off-label for weight loss. This drug is also experiencing shortages, and you can get the compounded tirzepatide.

Can I Switch From  Semaglutide to Tirzepatide?

Yes, it is possible to switch from semaglutide to tirzepatide. However, this switch is done gradually and should be done under the guidance of your healthcare provider. 

‍

They can assess your health and see if tirzepatide will be better for your weight loss journey. Note that you cannot use both semaglutide and tirzepatide at the same time to prevent fatal outcomes.

Comparing Semaglutide and Tirzepatide

Side by side Comparison of Benefits

‍

Similarities in Function

Semaglutide and tirzepatide share similar functions. These drugs mimic incretins to increase insulin release, delay gastric emptying, and reduce appetite, leading to better blood sugar control and weight loss.

Differences in Mechanisms and Efficacy

Both semaglutide and tirzepatide are glucagon-like peptide 1 (GLP-1) receptor agonists. In addition to GLP-1, tirzepatide also mimics another hormone in your body called the glucose-dependent insulinotropic polypeptide (GIP). This dual action makes tirzepatide potentially more effective than semaglutide in weight loss. The SURPASS-2 trial showed that tirzepatide may be more effective in weight loss than semaglutide. A clinical trial showed that users of tirzepatide lost an average of 21% of their body weight after 72 weeks. On the other hand, another trial showed that semaglutide caused a reduction in body weight of 15% in a similar timeframe.

Reasons for Switching from Semaglutide to Tirzepatide

Potential Benefits

While both drugs have shown promising results in weight loss, tirzepatide might have a slight edge over semaglutide. Individuals using semaglutide may decide to switch medications because some studies have shown that they may achieve more weight loss and also have better glycemic control with tirzepatide. 

Medical Recommendations

Your healthcare provider may recommend switching to tirzepatide after assessing your progress with semaglutide. If you are not experiencing the desired weight loss outcomes on semaglutide, they can recommend this switch.

Patient Experiences

A patient's experience with a medication is crucial in determining whether they become compliant with that drug. Some experience significant weight loss with semaglutide, while others do not. Patients who do not achieve their desired goals may decide to switch to tirzepatide for better weight loss.

Transition Process

Guidelines for Discontinuing Semaglutide

Discuss with your healthcare provider before discontinuing semaglutide. They can guide you on how to stop the drug properly. After taking your last dose of semaglutide before switching, do not start tirzepatide immediately. 

‍

You need to give your body time to wash out semaglutide; otherwise, you may experience serious side effects from a rapid transition to tirzepatide. Your healthcare provider will advise you on how long to wait, but a minimum of one week is recommended before commencing tirzepatide.

Initiating Tirzepatide Treatment

Your healthcare provider will assess your weight loss progress and determine the right starting dose of tirzepatide for you. However, regardless of how much semaglutide you were taking, the recommendation is that you start at 2.5 mg, the lowest tirzepatide dose. This allows you to understand how your body responds to the drug. Then, the dosage is slowly increased until you reach a maintenance dose with optimal weight loss results. 

Managing Side Effects During Transition

It is important that you keep an eye on how you respond to tirzepatide. You can keep a record of any side effects you experience while using the drug. There are also lifestyle changes that can help you mitigate these side effects, such as eating healthy and exercising regularly. 

‍

Fortunately, most side effects are usually transient and should resolve on their own within a few weeks. If the side effects persist, do not hesitate to contact your healthcare provider. 

Health and Safety Considerations

Clinical Studies and Trials

Various studies and trials demonstrate the safety of both semaglutide and tirzepatide. A systematic review of the various STEP (Semaglutide Treatment Effects in People with obesity) trials showed that 91.8% of participants experienced adverse reactions, with 77.2% of them experiencing gastrointestinal side effects. However, this review demonstrated that semaglutide is safe for long-term use, as only 6.5% of participants discontinued the drug due to its side effects. 

‍

In 2023, a systematic review was conducted to assess the safety of tirzepatide. This review found that tirzepatide's safety is acceptable and similar to that of semaglutide. Another study also showed that the side effects of lower doses of tirzepatide are not significantly different from those of semaglutide. However, the side effects were slightly more with 15 mg of tirzepatide.

Possible Risks and Side Effects

Both semaglutide and tirzepatide share similar side effects because of their actions on GLP-1. Some of the common side effects include nausea, vomiting, diarrhea, constipation, low blood sugar, and fatigue. These side effects are usually more prominent in the early weeks of treatment and gradually resolve as your body adjusts to the drugs.

‍

Note that potential side effects may occur more frequently with tirzepatide because of its dual action on two receptors. Less common side effects include gallbladder issues, pancreatitis, and vision changes. If you experience any side effects, discuss them with your healthcare provider.

‍

Similar to semaglutide, do not use tirzepatide if you have a family history of thyroid cancer or an endocrine tumor called multiple endocrine neoplasia syndrome type 2 (MEN 2).

Monitoring and Medical Supervision

Ensure you monitor your body's response while switching from semaglutide to tirzepatide. Maintain open communication with your healthcare provider and update them regularly about your progress. They can identify potentially dangerous side effects before they get out of hand. Also, your healthcare provider can adjust your tirzepatide dosage to better suit your needs for the best results.

Conclusion

Semaglutide and tirzepatide have shown promising results in weight loss management. However, some people might not experience significant weight loss with semaglutide and opt to switch to tirzepatide, which has been shown to be more effective. Considering the safety profiles of both medications, alongside medical guidance, is important for a safe transition. If you are thinking about switching from semaglutide to tirzepatide, contact your healthcare provider so that you can make an informed decision and get the best weight loss results.

Frequently Asked Questions

Is tirzepatide better than semaglutide for weight loss?

Both drugs are effective for weight loss; however, tirzepatide may be slightly better at weight management. Studies comparing both drugs have shown that tirzepatide resulted in more weight loss than semaglutide in a similar timeframe. 

How long does it take to lose weight on tirzepatide?

The duration of weight loss on tirzepatide varies among individuals. You may notice some weight loss within the first few weeks of using tirzepatide. Studies show that you may lose up to 21% of your starting weight after using tirzepatide for 72 weeks.

What are the results of tirzepatide after 1 month?

The weight loss results of tirzepatide after one month vary among individuals. Generally, studies have shown that you may experience changes in your appetite and up to 2% weight loss. 

When can I start tirzepatide after semaglutide?

Your healthcare provider will determine how long you should wait before starting tirzepatide. However, experts recommend that you wait for a minimum of one week after stopping semaglutide before commencing tirzepatide. This allows your body to wash out semaglutide and prevent serious side effects. 

How to maximize weight loss on tirzepatide?

Tirzepatide alone may not give you the best weight loss results. You need to combine the drug with healthy lifestyle habits like maintaining a healthy diet and exercising regularly to maximize weight loss on tirzepatide. Also, communicating with your healthcare provider every step of your journey can go a long way on your weight loss journey with tirzepatide.

Sources

1. https://www.pewresearch.org/short-reads/2024/03/21/as-obesity-rates-rise-in-the-us-and-worldwide-new-weight-loss-drugs-surge-in-popularity/
2. https://www.ncbi.nlm.nih.gov/books/NBK551568/
3. https://pubmed.ncbi.nlm.nih.gov/29412817/
4. https://www.nejm.org/doi/full/10.1056/NEJMoa2107519
5. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
6. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
7. https://www.ajconline.org/article/S0002-9149(24)00319-9/fulltext
8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084319/
9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159347/

Disclaimer

Off-Label Use: When discussing off-label uses, such as using Ozempic for weight loss, make it clear that this is not FDA-approved for that purpose. For example, you can add a disclaimer like: “While Ozempic is primarily approved for treating Type 2 diabetes, some healthcare providers may prescribe it off-label for weight loss. However, this use is not FDA-approved.”

Medical Advice Disclaimer: Clearly state that the article is for informational purposes only and not a substitute for professional medical advice. Encourage readers to consult with their healthcare provider before starting any new medication.